Predictive Value of CT-Based Radiomics in Distinguishing Renal Angiomyolipomas with Minimal Fat from Other Renal Tumors

Objectives. This study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from other solid renal tumors. Methods. This retrospective study included 58 patients with a postoperative pathologically confirmed AMLmf (observatio...

Full description

Saved in:
Bibliographic Details
Published inDisease markers Vol. 2022; pp. 1 - 8
Main Authors Han, Zhiwei, Zhu, Yuanqiang, Xu, Jingji, Wen, Didi, Xia, Yuwei, Zheng, Minwen, Yan, Tao, Wei, Mengqi
Format Journal Article
LanguageEnglish
Published United States Hindawi 2022
John Wiley & Sons, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objectives. This study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from other solid renal tumors. Methods. This retrospective study included 58 patients with a postoperative pathologically confirmed AMLmf (observation group) and 140 patients with other common renal tumors (control group). Non-contrast-enhanced CT and contrast-enhanced CT data were evaluated. Radiomics features were extracted from manually delineated volume of interest (VOIs). The least absolute shrinkage and selection operator (LASSO) regression was used for feature screening. Five classifiers, including logistic regression, multilayer perceptron (MLP), support vector machine (SVM), k-nearest neighbor (KNN), and logistic regression (LR), were used, with leave-out validation (128 training, 60 testing). The diagnostic performance of the classifier was evaluated and compared by receiver operating characteristic curve (ROC) analysis. Results. Among the 1029 extracted features, prediction models of AMLmf were composed, by 2, 10, 4, and 9 selected features for precontrast phase (PCP), corticomedullary phase (CMP), nephrographic phase (NP), and excretory phase (EP), respectively. Models of CMP and NP achieved adequate performance after using MLP classifier, with prediction accuracy of 0.767 (AUC 0.85, sensitivity 0.76, and specificity 0.78) and 0.783 (AUC 0.83, sensitivity 0.79, and specificity 0.78), respectively. MLP model of features selected from the combination of the all features had the best diagnostic performance (accuracy 0.8500, sensitivity 0.8095, specificity 0.9444, and AUC 0.9193). Conclusions. Radiomics features may help to distinguish benign AMLmf from common malignant kidney masses, which may contribute to the selection of interventions for renal tumors.
AbstractList Objectives. This study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from other solid renal tumors. Methods. This retrospective study included 58 patients with a postoperative pathologically confirmed AMLmf (observation group) and 140 patients with other common renal tumors (control group). Non-contrast-enhanced CT and contrast-enhanced CT data were evaluated. Radiomics features were extracted from manually delineated volume of interest (VOIs). The least absolute shrinkage and selection operator (LASSO) regression was used for feature screening. Five classifiers, including logistic regression, multilayer perceptron (MLP), support vector machine (SVM), k-nearest neighbor (KNN), and logistic regression (LR), were used, with leave-out validation (128 training, 60 testing). The diagnostic performance of the classifier was evaluated and compared by receiver operating characteristic curve (ROC) analysis. Results. Among the 1029 extracted features, prediction models of AMLmf were composed, by 2, 10, 4, and 9 selected features for precontrast phase (PCP), corticomedullary phase (CMP), nephrographic phase (NP), and excretory phase (EP), respectively. Models of CMP and NP achieved adequate performance after using MLP classifier, with prediction accuracy of 0.767 (AUC 0.85, sensitivity 0.76, and specificity 0.78) and 0.783 (AUC 0.83, sensitivity 0.79, and specificity 0.78), respectively. MLP model of features selected from the combination of the all features had the best diagnostic performance (accuracy 0.8500, sensitivity 0.8095, specificity 0.9444, and AUC 0.9193). Conclusions. Radiomics features may help to distinguish benign AMLmf from common malignant kidney masses, which may contribute to the selection of interventions for renal tumors.
This study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from other solid renal tumors. This retrospective study included 58 patients with a postoperative pathologically confirmed AMLmf (observation group) and 140 patients with other common renal tumors (control group). Non-contrast-enhanced CT and contrast-enhanced CT data were evaluated. Radiomics features were extracted from manually delineated volume of interest (VOIs). The least absolute shrinkage and selection operator (LASSO) regression was used for feature screening. Five classifiers, including logistic regression, multilayer perceptron (MLP), support vector machine (SVM), -nearest neighbor (KNN), and logistic regression (LR), were used, with leave-out validation (128 training, 60 testing). The diagnostic performance of the classifier was evaluated and compared by receiver operating characteristic curve (ROC) analysis. Among the 1029 extracted features, prediction models of AMLmf were composed, by 2, 10, 4, and 9 selected features for precontrast phase (PCP), corticomedullary phase (CMP), nephrographic phase (NP), and excretory phase (EP), respectively. Models of CMP and NP achieved adequate performance after using MLP classifier, with prediction accuracy of 0.767 (AUC 0.85, sensitivity 0.76, and specificity 0.78) and 0.783 (AUC 0.83, sensitivity 0.79, and specificity 0.78), respectively. MLP model of features selected from the combination of the all features had the best diagnostic performance (accuracy 0.8500, sensitivity 0.8095, specificity 0.9444, and AUC 0.9193). Radiomics features may help to distinguish benign AMLmf from common malignant kidney masses, which may contribute to the selection of interventions for renal tumors.
This study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from other solid renal tumors.ObjectivesThis study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from other solid renal tumors.This retrospective study included 58 patients with a postoperative pathologically confirmed AMLmf (observation group) and 140 patients with other common renal tumors (control group). Non-contrast-enhanced CT and contrast-enhanced CT data were evaluated. Radiomics features were extracted from manually delineated volume of interest (VOIs). The least absolute shrinkage and selection operator (LASSO) regression was used for feature screening. Five classifiers, including logistic regression, multilayer perceptron (MLP), support vector machine (SVM), k-nearest neighbor (KNN), and logistic regression (LR), were used, with leave-out validation (128 training, 60 testing). The diagnostic performance of the classifier was evaluated and compared by receiver operating characteristic curve (ROC) analysis.MethodsThis retrospective study included 58 patients with a postoperative pathologically confirmed AMLmf (observation group) and 140 patients with other common renal tumors (control group). Non-contrast-enhanced CT and contrast-enhanced CT data were evaluated. Radiomics features were extracted from manually delineated volume of interest (VOIs). The least absolute shrinkage and selection operator (LASSO) regression was used for feature screening. Five classifiers, including logistic regression, multilayer perceptron (MLP), support vector machine (SVM), k-nearest neighbor (KNN), and logistic regression (LR), were used, with leave-out validation (128 training, 60 testing). The diagnostic performance of the classifier was evaluated and compared by receiver operating characteristic curve (ROC) analysis.Among the 1029 extracted features, prediction models of AMLmf were composed, by 2, 10, 4, and 9 selected features for precontrast phase (PCP), corticomedullary phase (CMP), nephrographic phase (NP), and excretory phase (EP), respectively. Models of CMP and NP achieved adequate performance after using MLP classifier, with prediction accuracy of 0.767 (AUC 0.85, sensitivity 0.76, and specificity 0.78) and 0.783 (AUC 0.83, sensitivity 0.79, and specificity 0.78), respectively. MLP model of features selected from the combination of the all features had the best diagnostic performance (accuracy 0.8500, sensitivity 0.8095, specificity 0.9444, and AUC 0.9193).ResultsAmong the 1029 extracted features, prediction models of AMLmf were composed, by 2, 10, 4, and 9 selected features for precontrast phase (PCP), corticomedullary phase (CMP), nephrographic phase (NP), and excretory phase (EP), respectively. Models of CMP and NP achieved adequate performance after using MLP classifier, with prediction accuracy of 0.767 (AUC 0.85, sensitivity 0.76, and specificity 0.78) and 0.783 (AUC 0.83, sensitivity 0.79, and specificity 0.78), respectively. MLP model of features selected from the combination of the all features had the best diagnostic performance (accuracy 0.8500, sensitivity 0.8095, specificity 0.9444, and AUC 0.9193).Radiomics features may help to distinguish benign AMLmf from common malignant kidney masses, which may contribute to the selection of interventions for renal tumors.ConclusionsRadiomics features may help to distinguish benign AMLmf from common malignant kidney masses, which may contribute to the selection of interventions for renal tumors.
Objectives. This study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from other solid renal tumors. Methods. This retrospective study included 58 patients with a postoperative pathologically confirmed AMLmf (observation group) and 140 patients with other common renal tumors (control group). Non-contrast-enhanced CT and contrast-enhanced CT data were evaluated. Radiomics features were extracted from manually delineated volume of interest (VOIs). The least absolute shrinkage and selection operator (LASSO) regression was used for feature screening. Five classifiers, including logistic regression, multilayer perceptron (MLP), support vector machine (SVM), k -nearest neighbor (KNN), and logistic regression (LR), were used, with leave-out validation (128 training, 60 testing). The diagnostic performance of the classifier was evaluated and compared by receiver operating characteristic curve (ROC) analysis. Results. Among the 1029 extracted features, prediction models of AMLmf were composed, by 2, 10, 4, and 9 selected features for precontrast phase (PCP), corticomedullary phase (CMP), nephrographic phase (NP), and excretory phase (EP), respectively. Models of CMP and NP achieved adequate performance after using MLP classifier, with prediction accuracy of 0.767 (AUC 0.85, sensitivity 0.76, and specificity 0.78) and 0.783 (AUC 0.83, sensitivity 0.79, and specificity 0.78), respectively. MLP model of features selected from the combination of the all features had the best diagnostic performance (accuracy 0.8500, sensitivity 0.8095, specificity 0.9444, and AUC 0.9193). Conclusions. Radiomics features may help to distinguish benign AMLmf from common malignant kidney masses, which may contribute to the selection of interventions for renal tumors.
Author Wen, Didi
Han, Zhiwei
Xia, Yuwei
Xu, Jingji
Zheng, Minwen
Yan, Tao
Zhu, Yuanqiang
Wei, Mengqi
AuthorAffiliation 1 Department of Radiology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China
3 Department of Radiology, Xi'an XD Group Hospital, Xi'an, Shaanxi, China
2 Huiying Medical Technology Co., Ltd., Room A206, B2, Dongsheng Science and Technology Park, Haidian District, Beijing 100192, China
AuthorAffiliation_xml – name: 3 Department of Radiology, Xi'an XD Group Hospital, Xi'an, Shaanxi, China
– name: 1 Department of Radiology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China
– name: 2 Huiying Medical Technology Co., Ltd., Room A206, B2, Dongsheng Science and Technology Park, Haidian District, Beijing 100192, China
Author_xml – sequence: 1
  givenname: Zhiwei
  surname: Han
  fullname: Han, Zhiwei
  organization: Department of RadiologyXijing HospitalAir Force Medical UniversityXi’anShaanxiChinafmmu.edu.cn
– sequence: 2
  givenname: Yuanqiang
  surname: Zhu
  fullname: Zhu, Yuanqiang
  organization: Department of RadiologyXijing HospitalAir Force Medical UniversityXi’anShaanxiChinafmmu.edu.cn
– sequence: 3
  givenname: Jingji
  orcidid: 0000-0002-9767-0742
  surname: Xu
  fullname: Xu, Jingji
  organization: Department of RadiologyXijing HospitalAir Force Medical UniversityXi’anShaanxiChinafmmu.edu.cn
– sequence: 4
  givenname: Didi
  orcidid: 0000-0002-5176-0777
  surname: Wen
  fullname: Wen, Didi
  organization: Department of RadiologyXijing HospitalAir Force Medical UniversityXi’anShaanxiChinafmmu.edu.cn
– sequence: 5
  givenname: Yuwei
  orcidid: 0000-0002-6835-7618
  surname: Xia
  fullname: Xia, Yuwei
  organization: Huiying Medical Technology Co.Ltd.Room A206B2Dongsheng Science and Technology ParkHaidian DistrictBeijing 100192China
– sequence: 6
  givenname: Minwen
  surname: Zheng
  fullname: Zheng, Minwen
  organization: Department of RadiologyXijing HospitalAir Force Medical UniversityXi’anShaanxiChinafmmu.edu.cn
– sequence: 7
  givenname: Tao
  orcidid: 0000-0002-8073-691X
  surname: Yan
  fullname: Yan, Tao
  organization: Department of RadiologyXi’an XD Group HospitalXi’anShaanxiChina
– sequence: 8
  givenname: Mengqi
  orcidid: 0000-0002-9332-9301
  surname: Wei
  fullname: Wei, Mengqi
  organization: Department of RadiologyXijing HospitalAir Force Medical UniversityXi’anShaanxiChinafmmu.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35669501$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFrFDEUh4NU7LZ68ywBL4KOfclkMplLoW6tCpVKWb2GTCazmzKTrEmmS__7Zt2taEFP7_C-9-P3-I7QgfPOIPSSwHtCquqEAqUnDQFBaPMEzYioq0LwEg7QDGgtCqAMDtFRjDcAGWHNM3RYVpw3FZAZ2nwLprM62VuDf6hhMtj3eL4oPqhoOnytOutHqyO2Dp_bmKxbTjau8sDXxqkBn7llJu78YNd-VBFvbFrhr9bZMS8vVMJ98CO-SisT9heLafQhPkdPezVE82I_j9H3i4-L-efi8urTl_nZZaEZE6mgtNam5z3nAJpDX3LBecsJ0aw1tNNal7zsWqMEAyU0AaVaJeqeUahMw0V5jE53ueupHU2njUtBDXIdcsFwJ72y8u-Nsyu59LeyIbyGBnLAm31A8D8nE5McbdRmGJQzfoqS8poBCIA6o68foTd-CvnnX1RJaVbEMvXqz0a_qzw4yQDdATr4GIPppbZJJeu3Be0gCciteLkVL_fi89G7R0cPuf_A3-7wrLJTG_t_-h4iMLt9
CitedBy_id crossref_primary_10_1177_17562872231164803
crossref_primary_10_3390_ijms24054615
crossref_primary_10_1007_s44326_024_00033_y
crossref_primary_10_1016_j_ejro_2024_100608
Cites_doi 10.2214/ajr.180.3.1800755
10.1016/j.acra.2014.07.023
10.1016/j.urology.2009.11.082
10.1097/MOU.0b013e32833625f8
10.1073/pnas.1505935112
10.1016/j.ejrad.2017.04.007
10.1016/j.urology.2008.04.054
10.1200/JCO.2015.65.9128
10.1016/j.juro.2009.07.004
10.1016/j.crad.2012.08.028
10.1007/s00261-017-1144-1
10.2214/ajr.151.3.497
10.1136/bmj.g4797
10.1007/s00330-017-5118-z
10.2214/AJR.12.10204
10.1148/radiol.2020191145
10.1007/978-4-431-55531-5_5
10.1016/j.juro.2006.08.013
10.1177/0284185119830282
10.1002/mp.12828
10.1148/radiol.12111281
10.1007/s00261-017-1079-6
10.1007/s00261-016-1014-2
10.1016/j.clinimag.2014.09.008
10.1002/mp.12258
10.1016/j.eururo.2009.10.023
10.1016/j.urology.2008.08.519
10.1177/0284185115618547
10.1177/0284185113491087
10.1155/2017/1854027
10.2214/AJR.18.19551
10.1016/j.acra.2015.04.004
ContentType Journal Article
Copyright Copyright © 2022 Zhiwei Han et al.
Copyright © 2022 Zhiwei Han et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
Copyright © 2022 Zhiwei Han et al. 2022
Copyright_xml – notice: Copyright © 2022 Zhiwei Han et al.
– notice: Copyright © 2022 Zhiwei Han et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
– notice: Copyright © 2022 Zhiwei Han et al. 2022
DBID RHU
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7TK
8FD
C1K
FR3
P64
RC3
7X8
5PM
DOI 10.1155/2022/9108129
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Biotechnology Research Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts

MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1875-8630
Editor Zhu, Pei-Wen
Editor_xml – sequence: 1
  givenname: Pei-Wen
  surname: Zhu
  fullname: Zhu, Pei-Wen
EndPage 8
ExternalDocumentID PMC9167090
35669501
10_1155_2022_9108129
Genre Journal Article
GrantInformation_xml – fundername: Discipline Promotion Project of Xijing Hospital
  grantid: XJZT18MJ52
– fundername: National Science Foundation of Shaanxi Province
  grantid: 2020JQ-461
– fundername: Key Research and Development Plan of Shaanxi Province
  grantid: 2019SF-182
GroupedDBID ---
0R~
36B
4.4
5GY
5RE
5VS
AAFWJ
AAJEY
ABDBF
ABJNI
ACGFS
ACIWK
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
DU5
EAD
EAP
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
GROUPED_DOAJ
HYE
HZ~
IAO
IHR
INH
INR
IOS
ITC
KQ8
M48
O9-
OK1
P2P
RHU
RHW
RHX
RNS
RPM
SV3
TUS
24P
AAYXX
ACCMX
CITATION
H13
.GJ
29G
53G
AAFNC
ABUBZ
ACPQW
ACUHS
ADZMO
AFRHK
AGIAB
CAG
CGR
COF
CUY
CVF
ECM
EIF
EJD
IL9
IPNFZ
MET
MIO
NPM
RIG
ZGI
7QL
7QO
7TK
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
FR3
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c448t-227cef6f6600c60f36866b611c4be2dccc363dbea840a8c10aaba87f4205e9683
IEDL.DBID M48
ISSN 0278-0240
1875-8630
IngestDate Thu Aug 21 18:08:49 EDT 2025
Fri Jul 11 08:18:34 EDT 2025
Fri Jul 25 09:31:49 EDT 2025
Wed Feb 19 02:24:47 EST 2025
Tue Jul 01 04:22:25 EDT 2025
Thu Apr 24 23:03:28 EDT 2025
Sun Jun 02 18:49:12 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by/4.0
Copyright © 2022 Zhiwei Han et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c448t-227cef6f6600c60f36866b611c4be2dccc363dbea840a8c10aaba87f4205e9683
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Pei-Wen Zhu
ORCID 0000-0002-6835-7618
0000-0002-5176-0777
0000-0002-8073-691X
0000-0002-9767-0742
0000-0002-9332-9301
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2022/9108129
PMID 35669501
PQID 2673228124
PQPubID 2046413
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9167090
proquest_miscellaneous_2674008007
proquest_journals_2673228124
pubmed_primary_35669501
crossref_citationtrail_10_1155_2022_9108129
crossref_primary_10_1155_2022_9108129
hindawi_primary_10_1155_2022_9108129
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-00-00
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 2022-00-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Amsterdam
PublicationTitle Disease markers
PublicationTitleAlternate Dis Markers
PublicationYear 2022
Publisher Hindawi
John Wiley & Sons, Inc
Publisher_xml – name: Hindawi
– name: John Wiley & Sons, Inc
References 22
23
24
25
26
27
28
29
30
31
10
32
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – ident: 5
  doi: 10.2214/ajr.180.3.1800755
– ident: 27
  doi: 10.1016/j.acra.2014.07.023
– ident: 24
  doi: 10.1016/j.urology.2009.11.082
– ident: 7
  doi: 10.1097/MOU.0b013e32833625f8
– ident: 30
  doi: 10.1073/pnas.1505935112
– ident: 19
  doi: 10.1016/j.ejrad.2017.04.007
– ident: 22
  doi: 10.1016/j.urology.2008.04.054
– ident: 18
  doi: 10.1200/JCO.2015.65.9128
– ident: 21
  doi: 10.1016/j.juro.2009.07.004
– ident: 9
  doi: 10.1016/j.crad.2012.08.028
– ident: 14
  doi: 10.1007/s00261-017-1144-1
– ident: 25
  doi: 10.2214/ajr.151.3.497
– ident: 2
  doi: 10.1136/bmj.g4797
– ident: 28
  doi: 10.1007/s00330-017-5118-z
– ident: 20
  doi: 10.2214/AJR.12.10204
– ident: 17
  doi: 10.1148/radiol.2020191145
– ident: 4
  doi: 10.1007/978-4-431-55531-5_5
– ident: 23
  doi: 10.1016/j.juro.2006.08.013
– ident: 32
  doi: 10.1177/0284185119830282
– ident: 3
  doi: 10.1002/mp.12828
– ident: 26
  doi: 10.1148/radiol.12111281
– ident: 31
  doi: 10.1007/s00261-017-1079-6
– ident: 15
  doi: 10.1007/s00261-016-1014-2
– ident: 12
  doi: 10.1016/j.clinimag.2014.09.008
– ident: 29
  doi: 10.1002/mp.12258
– ident: 8
  doi: 10.1016/j.eururo.2009.10.023
– ident: 6
  doi: 10.1016/j.urology.2008.08.519
– ident: 11
  doi: 10.1177/0284185115618547
– ident: 10
  doi: 10.1177/0284185113491087
– ident: 1
  doi: 10.1155/2017/1854027
– ident: 13
  doi: 10.2214/AJR.18.19551
– ident: 16
  doi: 10.1016/j.acra.2015.04.004
SSID ssj0012949
Score 2.310602
Snippet Objectives. This study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from...
This study is aimed at determining whether CT-based radiomics models can help differentiate renal angiomyolipomas with minimal fat (AMLmf) from other solid...
SourceID pubmedcentral
proquest
pubmed
crossref
hindawi
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Accuracy
Adipocytes
Angiomyolipoma - diagnostic imaging
Artificial intelligence
Classifiers
Diagnostic systems
Feature extraction
Humans
Kidney Neoplasms - diagnostic imaging
Kidney Neoplasms - pathology
Kidneys
Machine learning
Medical imaging
Multilayer perceptrons
Patients
Prediction models
Radiomics
Regression
Retrospective Studies
Sensitivity
Support vector machines
Tomography
Tomography, X-Ray Computed
Tumors
SummonAdditionalLinks – databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fT9swED4NpKG9oA3YCGPISOxpikicxEkex4-qQipDqEx9ixzHgUjFQW0jxH-_u8SNVgYaL1Ein-3IZ_v7zmefAY68tNRhkfhujljhhiLxXClE4UZSBQXFnUwUHXAeXYrhTXgxiSY2SNL8Xxc-oh2Z5_wYUQ2hKF2DNexgZJQPJ72zgKcdy-UULBYRarm__VneFeR5f0cm72P1ErF8vj_yL8AZfIRNyxTZz061n-CdNluwMbK-8G14vJrRO01X7LecNprVJTsduyeISwW7lkVFB47nrDLsjAayuW269SZ2rduCzS1KPNXT6oH2CDFakWWjylT3mDiQC0YnT9gvIog2x7i5r2fzHbgZnI9Ph669RsFVaHstXM5jpUtRCuQ2SnhlIBIhUDW-CnPNC6VUIIIi1xJtPZko35Myl0lchtyLdCqS4DOsm9roXWCRxnZM6EHXG0VYkCrQAFW-r0tdcu3Aj2UTZ8rGGKerLqZZa2tEUUYKyaxCHPjeSz90sTVekTuy2vqP2P5SlZkdiPOMixinLGIxDhz2yTiEyC8ija6bViZsmXPswJdO831FAdLdNPJ8B-KVPtELUHju1RRT3bVhupF4x17q7b3t77_CB_rsVnf2YX0xa_Q35DuL_KDt7X8A8kD3gQ
  priority: 102
  providerName: Hindawi Publishing
Title Predictive Value of CT-Based Radiomics in Distinguishing Renal Angiomyolipomas with Minimal Fat from Other Renal Tumors
URI https://dx.doi.org/10.1155/2022/9108129
https://www.ncbi.nlm.nih.gov/pubmed/35669501
https://www.proquest.com/docview/2673228124
https://www.proquest.com/docview/2674008007
https://pubmed.ncbi.nlm.nih.gov/PMC9167090
Volume 2022
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Zb9QwEB61RaC-oHIHSmWk8oQCuew4D6iCwmoFWo7VLtq3yHGcNtLWaXc3Kv33zORY2KoIXqxEHjuKx_b3jY8ZgEMvKUyUS9_NECvcSEjPVULkLlc6zMnvpNR0wXn0RQyn0acZn21BH220a8DljaYdxZOaLuavf15cHeGAf9sMeM7Jfg_eIOwhViXbcAsxKaZYBqPo935CkLREOCB_sghi_RH4a6U3wOn2KVnFl-VN3PP6Eco_MGmwB3c7Msnetdq_B1vG3oc7o267_AFcflvQM81o7Iea14ZVBTueuO8RunI2VnlJd5KXrLTsA411e1K3S1JsbJqK7QlKXFXz8pyOETFatGWj0pZnmDlQK0aXU9hX4pBdiUl9Vi2WD2E6-Dg5HrpdpAVXo3m2coMg1qYQhUD6o4VXhEIKgdrzdZSZINdahyLMM6PQHFRS-55SmZJxEQUeN4mQ4SPYsZU1T4Bxg-0oKaEISBwr0jnaqNr3TWGKwDjwqm_iVHduyCkaxjxtzBHOU1JI2inEgZdr6fPW_cZf5A47bf1DbL9XZdp3tTQQMc5qRHQceLHOxlFGWyfKmqpuZKKGXMcOPG41v_5QiIw44Z7vQLzRJ9YC5MF7M8eWp40nb-TmsZd4T__zL5_BLr22K0D7sLNa1OY5cqJVdgDbn7_Lg6bTYzoezn4B440Hkw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictive+Value+of+CT-Based+Radiomics+in+Distinguishing+Renal+Angiomyolipomas+with+Minimal+Fat+from+Other+Renal+Tumors&rft.jtitle=Disease+markers&rft.au=Han%2C+Zhiwei&rft.au=Zhu%2C+Yuanqiang&rft.au=Xu%2C+Jingji&rft.au=Wen%2C+Didi&rft.date=2022&rft.issn=0278-0240&rft.eissn=1875-8630&rft.volume=2022&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1155%2F2022%2F9108129&rft.externalDBID=n%2Fa&rft.externalDocID=10_1155_2022_9108129
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-0240&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-0240&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-0240&client=summon